A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIENÂ® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy